Mission Vision & History
The gradual process through which Numantec acquires diverse and complementary companies is intended to represent the Group’s commitment and solidity with a view to the future.
The individual entities operate and cooperate in order to ensure cutting-edge medical and healthcare solutions, minimizing human error and optimizing individual performance, thus making the Numantec Group the next benchmark in the medical and healthcare sector.
MISSION
Helping patients live their everyday lives
Our mission is to improve patients’ quality of life and make their daily activities easier through high-performance devices fully focused on patients and end users.
VISION
Innovation and cohesion at the core of our work
The different entities that make up Numantec specialize in unique, innovative, and cutting-edge healthcare solutions. This constant commitment enables the Group to position itself as a benchmark in the global market. We listen to healthcare professionals and develop the best solutions to reduce human error and ensure optimal performance, always keeping the end patient at the center.
History: the Group
Storia: il Gruppo
1993
Foundation of Delta Med in Viadana (Mantua)
2017-2018
Acquisition of Tipromed Srl, BEL Srl and the Critical Care business unit of Alfa Med Srl
Oct. 2021
WBI acquires 90% of the shares of Delta Med S.p.A.
Jul 2022
Acquisition of Adria Med Srl
Sep. 2022
Acquisition of the Pentaferte Group (including Securmed Srl). Merger of Tipromed into Delta Med
Mar. 2023
Acquisition of DBM Srl
Jan. 2024
Acquisition of the global rights to the Saflo™ infusion devices from Infutech Ltd.
Aug. 2024
Acquisition of PHS Medical
Jan. 2025
Acquisition of Health Line – USA
Apr. 2025
Merger of BEL into Delta Med
Feb. 2026
Acquisition of the DualCap® product line from Merit Medical Systems, Inc.
1993
Nasce Delta Med
2017-2018
acquisizione di Tipromed, business unit di Alfa med e BEL
2021
WBI acquisisce il 90% del capitale Delta Med
2022
Acquisizione di Adria Med e Pentaferte
2023
Acquisizione D.B.M.